Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
289 |
|
| Actual shortage: | 4 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 16 (6%) | |
| Resolved: | 269 (93%) | |
Discontinuation Reports |
58 |
|
| To be discontinued: | 7 (12%) | |
| Discontinued: | 51 (88%) | |
| Reversed: | 0 (0%) | |
Late reports |
21 (6%) |
|
Overdue reports |
6 (55%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2018-12-20 | 2019-02-27 | 70230 |
| AVALIDE | 12.5MG 300MG | TABLET | Avoided shortage | 2022-04-14 | 2022-08-11 | 158890 |
| AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2022-08-11 | 2022-08-11 | 166530 |
| AVAPRO | 300MG | TABLET | Resolved | 2022-08-02 | 2022-09-17 | 165911 |
| AVAPRO | 300MG | TABLET | Resolved | 2021-12-02 | 2022-06-09 | 150376 |
| AVAPRO | 300MG | TABLET | Resolved | 2020-03-12 | 2020-04-22 | 108533 |
| AVAPRO | 300MG | TABLET | Resolved | 2019-11-29 | 2020-01-24 | 100061 |
| AVAPRO | 300MG | TABLET | Resolved | 2019-07-16 | 2019-11-05 | 89476 |
| AVAPRO | 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-29 | 75171 |
| AVAPRO | 150MG | TABLET | Resolved | 2022-01-21 | 2022-06-09 | 153358 |
| AVAPRO | 150MG | TABLET | Resolved | 2021-05-21 | 2021-08-11 | 139795 |
| AVAPRO | 150MG | TABLET | Resolved | 2020-07-10 | 2020-07-15 | 119930 |
| AVAPRO | 150MG | TABLET | Resolved | 2019-10-09 | 2020-01-24 | 95797 |
| AVAPRO | 75MG | TABLET | Resolved | 2021-12-16 | 2022-08-20 | 151325 |
| AVAPRO | 75MG | TABLET | Resolved | 2021-05-21 | 2021-06-19 | 139790 |
| AVAPRO | 75MG | TABLET | Avoided shortage | 2021-02-16 | 2021-03-19 | 134199 |
| AVAPRO | 75MG | TABLET | Resolved | 2020-04-07 | 2020-06-29 | 111392 |
| AVAPRO | 75MG | TABLET | Resolved | 2019-11-29 | 2020-02-05 | 100048 |
| AVAPRO | 75MG | TABLET | Resolved | 2019-07-12 | 2019-11-05 | 89212 |
| AVAPRO | 75MG | TABLET | Resolved | 2018-11-29 | 2019-02-27 | 68058 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIABETA | 2.5MG | TABLET | Discontinued | 2019-12-11 | 2020-08-04 | 100935 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57616 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57613 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57608 |
| FLAGYL | 10% | CREAM | Discontinued | 2024-03-28 | 2024-11-20 | 223877 |
| FLAGYL | 500MG | CAPSULE | Discontinued | 2023-03-22 | 2023-03-22 | 187634 |
| IMOVANE | 5.0MG | TABLET | To be discontinued | 2022-05-16 | 2022-05-16 | 160688 |
| JEVTANA | 40MG | SOLUTION | Discontinued | 2023-06-21 | 2023-09-13 | 196086 |
| KEVZARA | 150MG | SOLUTION | Discontinued | 2022-07-12 | 2022-08-02 | 164491 |
| LIBTAYO | 250MG | SOLUTION | Discontinued | 2023-12-06 | 2023-12-09 | 212566 |
| MOZOBIL | 20MG | SOLUTION | To be discontinued | 2025-03-31 | 2025-03-31 | 253686 |
| MYOCHRYSINE | 50MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86073 |
| MYOCHRYSINE | 25MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86070 |
| MYOCHRYSINE | 10MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86067 |
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98374 |
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98371 |
| NOVAHISTINE DH | 10MG 1.7MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98377 |
| PEDIAPRED | 5MG | SOLUTION | Discontinued | 2023-09-28 | 2023-12-19 | 205412 |
| PHISOHEX | 3% | EMULSION | Discontinued | 2017-03-20 | 2017-03-20 | 3696 |
| PLAVIX | 300MG | TABLET | To be discontinued | 2019-12-11 | 2019-12-11 | 100941 |